NCT01948609View on ClinicalTrials.gov

Prospective Research of Outcomes After Salpingo-oophorectomy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
BRCA1 Gene MutationBRCA2 Gene Mutation
Trial Locations (1)

94115

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

University of California, San Francisco

OTHER

NCT01948609 - Prospective Research of Outcomes After Salpingo-oophorectomy | Biotech Hunter | Biotech Hunter